The Haute Autorité de Santé "maintains the limit of 55 years of age for Vaxzevria", aka AstraZeneca's vaccine, because of the benefit/risk ratio related to rare cases of thrombosis. This notice follows the government's demand as they wish to extend its access to all volunteering French as it is already happening in Germany.